Take Control: Medical Device Supply Chain Compliance

How medical device teams can prepare for 2026 regulatory change across procurement, risk, and compliance

Medical device supply chains are under pressure from every direction. Chemical restrictions are tightening, sustainability requirements are expanding, and due diligence expectations are rising across markets.

In our Take Control: Medical Device Supply Chain Compliance webinar, Source Intelligence leaders and industry advisors break down what’s driving complexity through 2026, and what teams can do now to reduce disruption risk, accelerate answers, and improve decision-making across the business.

Turn supplier compliance chaos into clear, defensible decisions.

This webinar examines the 2026 compliance drivers shaping medical device supply chains, including EU MDR expectations, REACH and RoHS updates, PFAS restrictions, and growing EPR obligations. You’ll learn how procurement and risk leaders can align on shared material and supplier data, identify “golden screw” risks, and make faster, defensible decisions across complex bills of material.

Use the form below to watch the webinar recording.

Watch the webinar

What’s covered in the webinar

Medical device compliance is becoming more complex across chemicals, traceability, and reporting obligations. This session focuses on the regulatory areas creating the most operational risk and explains how teams can respond with better data, visibility, and prioritization.  

The regulatory landscape shaping medical devices in 2026

How the regulatory areas driving the greatest concern into 2026, including EU MDR, REACH and RoHS updates, PFAS restrictions, conflict minerals, Proposition 65, EPR programs, and emerging obsolescence risks.

EU MDR expectations across the product lifecycle

How EU MDR requirements span design, manufacturing, and post-market surveillance, increasing expectations for documentation, monitoring, and ongoing updates across medical device portfolios.

Evolving EU chemical requirements under REACH

How anticipated updates and stronger enforcement under EU chemicals rules may require more rigorous supply chain transparency and more defensible substance-level data.

RoHS exemption phase-outs and material certainty

How expiring exemptions, particularly for lead in metal alloys, require greater certainty around material composition in medical device components.

PFAS bans and portfolio-level risk exposure

How widespread PFAS use, expanding U.S. state bans, and supplier phase-outs are creating portfolio-level risk that cannot be managed through surface-level supplier attestations.

Packaging traceability and sourcing transparency

Why traceability expectations now extend to packaging materials, requiring deeper visibility into sourcing locations and extractive origins.

The rapid expansion of EPR obligations

How rapidly growing EPR programs, particularly across U.S. states, are increasing reporting complexity and raising the cost of inaccurate or late filings.

Why watch the full webinar?

Many medical device organizations are facing the same challenge: growing compliance scope without growing resources. This webinar helps teams move from reactive fire drills to repeatable, cross-functional workflows. 

You’ll come away better equipped to: 

• Identify “golden screw” risks that can stall revenue, even in complex BOMs 
• Prioritize high-risk, high-revenue product families with a structured approach 
• Reduce internal hot-potato cycles by centralizing reliable compliance answers 
• Reuse compliance data across procurement, risk management, and trade needs 
• Improve speed and confidence when leadership asks, “Are we exposed?” 

Meet the speakers

Travis Miller – Chief Strategy Officer and General Counsel, Source Intelligence

Travis is the Chief Strategy Officer and General Counsel at Source Intelligence. With 20+ years of experience in compliance, sustainability, and legal risk, he previously served as Google’s Head of Supply Chain Compliance and brings a unique perspective as a former user of Source Intelligence’s C-MAP technology.

David Shillingford - Strategic Advisor, Supply Chain Risk and Analytics

David is a seasoned supply chain and risk management leader with experience across diverse industries. He co-founded Everstream Analytics and has worked extensively at the intersection of global supply chains, data, and operational resilience. 

Watch the webinar to see how medical device teams can reduce disruption risk and respond faster in 2026.